Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound capable of reducing hypeluricemia and relieving gout symptoms in acute attack period

A gout acute attack and complex technology, applied in the field of non-medical treatment, can solve the problems affecting the clinical application of traditional Chinese medicine, exfoliative dermatitis, and small side effects, achieve good clinical significance and medicinal value, reduce arthritic reactions, reduce The effect of uric acid production

Inactive Publication Date: 2019-01-04
广州市健全家源信息科技有限公司
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Western medicine for the treatment of hyperuricemia mainly uses allopurinol to inhibit the production of uric acid; the treatment of gout is mainly anti-inflammatory and analgesic, and commonly used anti-gout drugs have many side effects. Serious ones, such as allopurinol, can cause exfoliative dermatitis, and many Patient can't tolerate
Due to the low cost and small side effects of traditional Chinese medicine, especially the treatment of traditional Chinese medicine can regulate the body constitution, it has been accepted by a large number of patients, but the trouble of decocting has affected the clinical application of traditional Chinese medicine; Problems such as failure to achieve efficacy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound capable of reducing hypeluricemia and relieving gout symptoms in acute attack period
  • Compound capable of reducing hypeluricemia and relieving gout symptoms in acute attack period
  • Compound capable of reducing hypeluricemia and relieving gout symptoms in acute attack period

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] A compound for reducing hyperuric acid and relieving the symptoms of acute attack of gout, including 1g of Moringa oleifera powder processed and extracted from young leaves of Moringa oleifera at 10°C, 10g of L-glutamine, and probiotics with 120 billion active bacteria Bacteria, among which the probiotics include Bifidobacterium lactis with 50 billion active bacteria, Lactobacillus acidophilus with 35 billion active bacteria and Lactobacillus rhamnosus with 35 billion active bacteria.

[0023] After waiting for the patient, score the joint condition (joint pain, joint redness, joint tenderness and joint mobility disorder) before and after treatment, and count the effective rate, as well as the change of blood uric acid before and after treatment.

Embodiment 2

[0025] A compound for reducing hyperuric acid and relieving the symptoms of acute attack of gout, including 2g of Moringa oleifera powder processed and extracted from shelled Moringa oleifera seeds at 40°C, 30g of L-glutamine, and 80 billion active bacteria probiotics, including 40 billion active bacteria of Bifidobacterium lactis, 20 billion active bacteria of Lactobacillus acidophilus and 20 billion active bacteria of Lactobacillus rhamnosus.

Embodiment 3

[0027] A compound that reduces high uric acid and relieves the symptoms of acute gout, including 4g of Moringa oleifera leaves processed and extracted at 30°C to make Moringa oleifera powder, 20g of L-glutamine and 150 billion active The probiotics contain 100 billion active bacteria of Bifidobacterium lactis, 25 billion active bacteria of Lactobacillus acidophilus and 25 billion active bacteria of Lactobacillus rhamnosus.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound capable of reducing hypeluricemia and relieving gout symptoms in an acute attack period. The compound comprises probiotics, moringa powder and L-glutamine and has small side effects; the compound facilitates discharge of hypeluricemia and can regulate internal environments, regulate metabolic patterns and reduce blood uric acid; the compound can significantly reduce drastic inflammatory reactions, take effect within 10-12 h and greatly relieve and even completely eliminate swelling, heat pain, joint limitation and other symptoms in the acute attack period; the compound has very bright clinical application prospects.

Description

technical field [0001] The invention belongs to the field of non-medicine treatment, and relates to a compound for reducing high uric acid and relieving symptoms of gout acute attack. Background technique [0002] Along with economic development, people's living standard causes the improvement of dietary structure. Today's four highs are common and frequently-occurring diseases, among which the incidence of uric acidemia is extremely high, accounting for more than a quarter of the population, and there is an increasing trend. Long-term high blood uric acid rises, and urate crystals can be deposited in pancreatic islet B cells, resulting in impaired function and diabetes. Hyperuricemia can directly deposit uric acid crystals on the arteriolar wall to damage the arterial intima, aggravating hypertension and coronary heart disease. Hyperuricemia can promote the oxidation of low-density lipoprotein cholesterol and lipid peroxidation, resulting in increased blood lipids. [00...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/185A61P19/06A23L33/10A23L33/175A23L33/135A61K31/198A61K35/745A61K35/747
CPCA61P19/06A23L33/10A23L33/135A23L33/175A61K31/198A61K35/745A61K35/747A61K36/185A23V2002/00A61K2300/00A23V2200/30A23V2250/062A23V2400/531A23V2400/113A23V2400/175
Inventor 黄献军
Owner 广州市健全家源信息科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com